Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,735
archived clinical trials in
Psoriasis

Psoriasis Inflammation and Systemic Co Morbidities
Psoriasis Inflammation and Systemic Co-Morbidities: Is it Preventable or Reversible?
Status: Enrolling
Updated:  2/7/2018
Rockefeller University
2432
mi
from 91732
New York, NY
Psoriasis Inflammation and Systemic Co Morbidities
Psoriasis Inflammation and Systemic Co-Morbidities: Is it Preventable or Reversible?
Status: Enrolling
Updated: 2/7/2018
Rockefeller University
2432
mi
from 91732
New York, NY
Click here to add this to my saved trials
Pharmacokinetics and Metabolism of [14C]BMS-986165 in Healthy Male Participants
Pharmacokinetics and Metabolism of [14C]BMS-986165 in Healthy Male Participants
Status: Enrolling
Updated:  2/8/2018
Covance Madison Clinical Research Unit
1659
mi
from 91732
Madison, WI
Pharmacokinetics and Metabolism of [14C]BMS-986165 in Healthy Male Participants
Pharmacokinetics and Metabolism of [14C]BMS-986165 in Healthy Male Participants
Status: Enrolling
Updated: 2/8/2018
Covance Madison Clinical Research Unit
1659
mi
from 91732
Madison, WI
Click here to add this to my saved trials
Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis
A Randomized, Double Blind, Parallel Group, Placebo-controlled Trial to Study the Efficacy and Safety of Two Oral Doses of Prurisol Administered Twice Daily for Twelve Weeks to Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated:  2/9/2018
Clinical Research Facility
14
mi
from 91732
Glendale, AZ
Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis
A Randomized, Double Blind, Parallel Group, Placebo-controlled Trial to Study the Efficacy and Safety of Two Oral Doses of Prurisol Administered Twice Daily for Twelve Weeks to Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 2/9/2018
Clinical Research Facility
14
mi
from 91732
Glendale, AZ
Click here to add this to my saved trials
Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis
A Randomized, Double Blind, Parallel Group, Placebo-controlled Trial to Study the Efficacy and Safety of Two Oral Doses of Prurisol Administered Twice Daily for Twelve Weeks to Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated:  2/9/2018
Study Center
1419
mi
from 91732
Hot Springs, AR
Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis
A Randomized, Double Blind, Parallel Group, Placebo-controlled Trial to Study the Efficacy and Safety of Two Oral Doses of Prurisol Administered Twice Daily for Twelve Weeks to Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 2/9/2018
Study Center
1419
mi
from 91732
Hot Springs, AR
Click here to add this to my saved trials
Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis
A Randomized, Double Blind, Parallel Group, Placebo-controlled Trial to Study the Efficacy and Safety of Two Oral Doses of Prurisol Administered Twice Daily for Twelve Weeks to Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated:  2/9/2018
Clinical Study Site
58
mi
from 91732
Murrieta, CA
Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis
A Randomized, Double Blind, Parallel Group, Placebo-controlled Trial to Study the Efficacy and Safety of Two Oral Doses of Prurisol Administered Twice Daily for Twelve Weeks to Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 2/9/2018
Clinical Study Site
58
mi
from 91732
Murrieta, CA
Click here to add this to my saved trials
Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis
A Randomized, Double Blind, Parallel Group, Placebo-controlled Trial to Study the Efficacy and Safety of Two Oral Doses of Prurisol Administered Twice Daily for Twelve Weeks to Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated:  2/9/2018
Clinical Study Site
70
mi
from 91732
Oceanside, CA
Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis
A Randomized, Double Blind, Parallel Group, Placebo-controlled Trial to Study the Efficacy and Safety of Two Oral Doses of Prurisol Administered Twice Daily for Twelve Weeks to Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 2/9/2018
Clinical Study Site
70
mi
from 91732
Oceanside, CA
Click here to add this to my saved trials
Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis
A Randomized, Double Blind, Parallel Group, Placebo-controlled Trial to Study the Efficacy and Safety of Two Oral Doses of Prurisol Administered Twice Daily for Twelve Weeks to Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated:  2/9/2018
Clinical Research Facility
817
mi
from 91732
Denver, CO
Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis
A Randomized, Double Blind, Parallel Group, Placebo-controlled Trial to Study the Efficacy and Safety of Two Oral Doses of Prurisol Administered Twice Daily for Twelve Weeks to Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 2/9/2018
Clinical Research Facility
817
mi
from 91732
Denver, CO
Click here to add this to my saved trials
Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis
A Randomized, Double Blind, Parallel Group, Placebo-controlled Trial to Study the Efficacy and Safety of Two Oral Doses of Prurisol Administered Twice Daily for Twelve Weeks to Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated:  2/9/2018
Clinical Trial Site
817
mi
from 91732
Denver, CO
Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis
A Randomized, Double Blind, Parallel Group, Placebo-controlled Trial to Study the Efficacy and Safety of Two Oral Doses of Prurisol Administered Twice Daily for Twelve Weeks to Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 2/9/2018
Clinical Trial Site
817
mi
from 91732
Denver, CO
Click here to add this to my saved trials
Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis
A Randomized, Double Blind, Parallel Group, Placebo-controlled Trial to Study the Efficacy and Safety of Two Oral Doses of Prurisol Administered Twice Daily for Twelve Weeks to Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated:  2/9/2018
Clinical Research Facility
2191
mi
from 91732
Port Orange, FL
Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis
A Randomized, Double Blind, Parallel Group, Placebo-controlled Trial to Study the Efficacy and Safety of Two Oral Doses of Prurisol Administered Twice Daily for Twelve Weeks to Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 2/9/2018
Clinical Research Facility
2191
mi
from 91732
Port Orange, FL
Click here to add this to my saved trials
Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis
A Randomized, Double Blind, Parallel Group, Placebo-controlled Trial to Study the Efficacy and Safety of Two Oral Doses of Prurisol Administered Twice Daily for Twelve Weeks to Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated:  2/9/2018
Clinical Trial Site
2136
mi
from 91732
Tampa, FL
Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis
A Randomized, Double Blind, Parallel Group, Placebo-controlled Trial to Study the Efficacy and Safety of Two Oral Doses of Prurisol Administered Twice Daily for Twelve Weeks to Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 2/9/2018
Clinical Trial Site
2136
mi
from 91732
Tampa, FL
Click here to add this to my saved trials
Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis
A Randomized, Double Blind, Parallel Group, Placebo-controlled Trial to Study the Efficacy and Safety of Two Oral Doses of Prurisol Administered Twice Daily for Twelve Weeks to Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated:  2/9/2018
Clinical Research Facility
1813
mi
from 91732
Louisville, KY
Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis
A Randomized, Double Blind, Parallel Group, Placebo-controlled Trial to Study the Efficacy and Safety of Two Oral Doses of Prurisol Administered Twice Daily for Twelve Weeks to Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 2/9/2018
Clinical Research Facility
1813
mi
from 91732
Louisville, KY
Click here to add this to my saved trials
Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis
A Randomized, Double Blind, Parallel Group, Placebo-controlled Trial to Study the Efficacy and Safety of Two Oral Doses of Prurisol Administered Twice Daily for Twelve Weeks to Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated:  2/9/2018
Clinical Study Site
1950
mi
from 91732
Clarkston, MI
Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis
A Randomized, Double Blind, Parallel Group, Placebo-controlled Trial to Study the Efficacy and Safety of Two Oral Doses of Prurisol Administered Twice Daily for Twelve Weeks to Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 2/9/2018
Clinical Study Site
1950
mi
from 91732
Clarkston, MI
Click here to add this to my saved trials
Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis
A Randomized, Double Blind, Parallel Group, Placebo-controlled Trial to Study the Efficacy and Safety of Two Oral Doses of Prurisol Administered Twice Daily for Twelve Weeks to Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated:  2/9/2018
Clinical Study Site
1573
mi
from 91732
Saint Louis, MO
Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis
A Randomized, Double Blind, Parallel Group, Placebo-controlled Trial to Study the Efficacy and Safety of Two Oral Doses of Prurisol Administered Twice Daily for Twelve Weeks to Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 2/9/2018
Clinical Study Site
1573
mi
from 91732
Saint Louis, MO
Click here to add this to my saved trials
Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis
A Randomized, Double Blind, Parallel Group, Placebo-controlled Trial to Study the Efficacy and Safety of Two Oral Doses of Prurisol Administered Twice Daily for Twelve Weeks to Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated:  2/9/2018
Clinical Study Site
2591
mi
from 91732
Portsmouth, NH
Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis
A Randomized, Double Blind, Parallel Group, Placebo-controlled Trial to Study the Efficacy and Safety of Two Oral Doses of Prurisol Administered Twice Daily for Twelve Weeks to Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 2/9/2018
Clinical Study Site
2591
mi
from 91732
Portsmouth, NH
Click here to add this to my saved trials
Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis
A Randomized, Double Blind, Parallel Group, Placebo-controlled Trial to Study the Efficacy and Safety of Two Oral Doses of Prurisol Administered Twice Daily for Twelve Weeks to Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated:  2/9/2018
Clinical Study Site
2388
mi
from 91732
Berlin, NJ
Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis
A Randomized, Double Blind, Parallel Group, Placebo-controlled Trial to Study the Efficacy and Safety of Two Oral Doses of Prurisol Administered Twice Daily for Twelve Weeks to Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 2/9/2018
Clinical Study Site
2388
mi
from 91732
Berlin, NJ
Click here to add this to my saved trials
Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis
A Randomized, Double Blind, Parallel Group, Placebo-controlled Trial to Study the Efficacy and Safety of Two Oral Doses of Prurisol Administered Twice Daily for Twelve Weeks to Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated:  2/9/2018
Clinical Site
2435
mi
from 91732
New York, NY
Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis
A Randomized, Double Blind, Parallel Group, Placebo-controlled Trial to Study the Efficacy and Safety of Two Oral Doses of Prurisol Administered Twice Daily for Twelve Weeks to Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 2/9/2018
Clinical Site
2435
mi
from 91732
New York, NY
Click here to add this to my saved trials
Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis
A Randomized, Double Blind, Parallel Group, Placebo-controlled Trial to Study the Efficacy and Safety of Two Oral Doses of Prurisol Administered Twice Daily for Twelve Weeks to Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated:  2/9/2018
Clinical Trial Site
828
mi
from 91732
Portland, OR
Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis
A Randomized, Double Blind, Parallel Group, Placebo-controlled Trial to Study the Efficacy and Safety of Two Oral Doses of Prurisol Administered Twice Daily for Twelve Weeks to Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 2/9/2018
Clinical Trial Site
828
mi
from 91732
Portland, OR
Click here to add this to my saved trials
Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis
A Randomized, Double Blind, Parallel Group, Placebo-controlled Trial to Study the Efficacy and Safety of Two Oral Doses of Prurisol Administered Twice Daily for Twelve Weeks to Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated:  2/9/2018
Clinical Research Facility
2558
mi
from 91732
Johnston, RI
Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis
A Randomized, Double Blind, Parallel Group, Placebo-controlled Trial to Study the Efficacy and Safety of Two Oral Doses of Prurisol Administered Twice Daily for Twelve Weeks to Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 2/9/2018
Clinical Research Facility
2558
mi
from 91732
Johnston, RI
Click here to add this to my saved trials
Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis
A Randomized, Double Blind, Parallel Group, Placebo-controlled Trial to Study the Efficacy and Safety of Two Oral Doses of Prurisol Administered Twice Daily for Twelve Weeks to Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated:  2/9/2018
Clinical Site
1358
mi
from 91732
Houston, TX
Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis
A Randomized, Double Blind, Parallel Group, Placebo-controlled Trial to Study the Efficacy and Safety of Two Oral Doses of Prurisol Administered Twice Daily for Twelve Weeks to Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 2/9/2018
Clinical Site
1358
mi
from 91732
Houston, TX
Click here to add this to my saved trials
Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis
A Randomized, Double Blind, Parallel Group, Placebo-controlled Trial to Study the Efficacy and Safety of Two Oral Doses of Prurisol Administered Twice Daily for Twelve Weeks to Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated:  2/9/2018
Clinical Study Site
1215
mi
from 91732
Pflugerville, TX
Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis
A Randomized, Double Blind, Parallel Group, Placebo-controlled Trial to Study the Efficacy and Safety of Two Oral Doses of Prurisol Administered Twice Daily for Twelve Weeks to Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 2/9/2018
Clinical Study Site
1215
mi
from 91732
Pflugerville, TX
Click here to add this to my saved trials
Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis
A Randomized, Double Blind, Parallel Group, Placebo-controlled Trial to Study the Efficacy and Safety of Two Oral Doses of Prurisol Administered Twice Daily for Twelve Weeks to Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated:  2/9/2018
Clinical Study Site
1188
mi
from 91732
San Antonio, TX
Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis
A Randomized, Double Blind, Parallel Group, Placebo-controlled Trial to Study the Efficacy and Safety of Two Oral Doses of Prurisol Administered Twice Daily for Twelve Weeks to Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 2/9/2018
Clinical Study Site
1188
mi
from 91732
San Antonio, TX
Click here to add this to my saved trials
Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis
A Randomized, Double Blind, Parallel Group, Placebo-controlled Trial to Study the Efficacy and Safety of Two Oral Doses of Prurisol Administered Twice Daily for Twelve Weeks to Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated:  2/9/2018
Clinical Research Facility
1188
mi
from 91732
San Antonio, TX
Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis
A Randomized, Double Blind, Parallel Group, Placebo-controlled Trial to Study the Efficacy and Safety of Two Oral Doses of Prurisol Administered Twice Daily for Twelve Weeks to Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 2/9/2018
Clinical Research Facility
1188
mi
from 91732
San Antonio, TX
Click here to add this to my saved trials
Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis
A Randomized, Double Blind, Parallel Group, Placebo-controlled Trial to Study the Efficacy and Safety of Two Oral Doses of Prurisol Administered Twice Daily for Twelve Weeks to Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated:  2/9/2018
Clinical Research Facility
13
mi
from 91732
Los Angeles, CA
Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis
A Randomized, Double Blind, Parallel Group, Placebo-controlled Trial to Study the Efficacy and Safety of Two Oral Doses of Prurisol Administered Twice Daily for Twelve Weeks to Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 2/9/2018
Clinical Research Facility
13
mi
from 91732
Los Angeles, CA
Click here to add this to my saved trials
Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis
A Randomized, Double Blind, Parallel Group, Placebo-controlled Trial to Study the Efficacy and Safety of Two Oral Doses of Prurisol Administered Twice Daily for Twelve Weeks to Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated:  2/9/2018
Clinical Research Facility
26
mi
from 91732
Sherman Oaks, CA
Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis
A Randomized, Double Blind, Parallel Group, Placebo-controlled Trial to Study the Efficacy and Safety of Two Oral Doses of Prurisol Administered Twice Daily for Twelve Weeks to Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 2/9/2018
Clinical Research Facility
26
mi
from 91732
Sherman Oaks, CA
Click here to add this to my saved trials
Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis
A Randomized, Double Blind, Parallel Group, Placebo-controlled Trial to Study the Efficacy and Safety of Two Oral Doses of Prurisol Administered Twice Daily for Twelve Weeks to Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated:  2/9/2018
Clinical Research Facility
2131
mi
from 91732
Savannah, GA
Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis
A Randomized, Double Blind, Parallel Group, Placebo-controlled Trial to Study the Efficacy and Safety of Two Oral Doses of Prurisol Administered Twice Daily for Twelve Weeks to Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 2/9/2018
Clinical Research Facility
2131
mi
from 91732
Savannah, GA
Click here to add this to my saved trials
Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis
A Randomized, Double Blind, Parallel Group, Placebo-controlled Trial to Study the Efficacy and Safety of Two Oral Doses of Prurisol Administered Twice Daily for Twelve Weeks to Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated:  2/9/2018
Study Center
1713
mi
from 91732
Arlington Heights, IL
Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis
A Randomized, Double Blind, Parallel Group, Placebo-controlled Trial to Study the Efficacy and Safety of Two Oral Doses of Prurisol Administered Twice Daily for Twelve Weeks to Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 2/9/2018
Study Center
1713
mi
from 91732
Arlington Heights, IL
Click here to add this to my saved trials
Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis
A Randomized, Double Blind, Parallel Group, Placebo-controlled Trial to Study the Efficacy and Safety of Two Oral Doses of Prurisol Administered Twice Daily for Twelve Weeks to Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated:  2/9/2018
Clinical Study Site
1798
mi
from 91732
South Bend, IN
Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis
A Randomized, Double Blind, Parallel Group, Placebo-controlled Trial to Study the Efficacy and Safety of Two Oral Doses of Prurisol Administered Twice Daily for Twelve Weeks to Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 2/9/2018
Clinical Study Site
1798
mi
from 91732
South Bend, IN
Click here to add this to my saved trials
Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis
A Randomized, Double Blind, Parallel Group, Placebo-controlled Trial to Study the Efficacy and Safety of Two Oral Doses of Prurisol Administered Twice Daily for Twelve Weeks to Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated:  2/9/2018
Study Center
1332
mi
from 91732
Overland Park, KA
Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis
A Randomized, Double Blind, Parallel Group, Placebo-controlled Trial to Study the Efficacy and Safety of Two Oral Doses of Prurisol Administered Twice Daily for Twelve Weeks to Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 2/9/2018
Study Center
1332
mi
from 91732
Overland Park, KA
Click here to add this to my saved trials
Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis
A Randomized, Double Blind, Parallel Group, Placebo-controlled Trial to Study the Efficacy and Safety of Two Oral Doses of Prurisol Administered Twice Daily for Twelve Weeks to Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated:  2/9/2018
Clinical Research Facility
208
mi
from 91732
Las Vegas, NV
Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis
A Randomized, Double Blind, Parallel Group, Placebo-controlled Trial to Study the Efficacy and Safety of Two Oral Doses of Prurisol Administered Twice Daily for Twelve Weeks to Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 2/9/2018
Clinical Research Facility
208
mi
from 91732
Las Vegas, NV
Click here to add this to my saved trials
Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis
A Randomized, Double Blind, Parallel Group, Placebo-controlled Trial to Study the Efficacy and Safety of Two Oral Doses of Prurisol Administered Twice Daily for Twelve Weeks to Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated:  2/9/2018
Study Center
1223
mi
from 91732
Austin, TX
Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis
A Randomized, Double Blind, Parallel Group, Placebo-controlled Trial to Study the Efficacy and Safety of Two Oral Doses of Prurisol Administered Twice Daily for Twelve Weeks to Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 2/9/2018
Study Center
1223
mi
from 91732
Austin, TX
Click here to add this to my saved trials
Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis
A Randomized, Double Blind, Parallel Group, Placebo-controlled Trial to Study the Efficacy and Safety of Two Oral Doses of Prurisol Administered Twice Daily for Twelve Weeks to Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated:  2/9/2018
Clinical Research Facility
1376
mi
from 91732
Webster, TX
Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis
A Randomized, Double Blind, Parallel Group, Placebo-controlled Trial to Study the Efficacy and Safety of Two Oral Doses of Prurisol Administered Twice Daily for Twelve Weeks to Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 2/9/2018
Clinical Research Facility
1376
mi
from 91732
Webster, TX
Click here to add this to my saved trials
Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis
A Randomized, Double Blind, Parallel Group, Placebo-controlled Trial to Study the Efficacy and Safety of Two Oral Doses of Prurisol Administered Twice Daily for Twelve Weeks to Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated:  2/9/2018
Study Center
2206
mi
from 91732
Charlottesville, VA
Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis
A Randomized, Double Blind, Parallel Group, Placebo-controlled Trial to Study the Efficacy and Safety of Two Oral Doses of Prurisol Administered Twice Daily for Twelve Weeks to Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 2/9/2018
Study Center
2206
mi
from 91732
Charlottesville, VA
Click here to add this to my saved trials
Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis
A Randomized, Double Blind, Parallel Group, Placebo-controlled Trial to Study the Efficacy and Safety of Two Oral Doses of Prurisol Administered Twice Daily for Twelve Weeks to Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated:  2/9/2018
Study Center
14
mi
from 91732
Los Angeles, CA
Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis
A Randomized, Double Blind, Parallel Group, Placebo-controlled Trial to Study the Efficacy and Safety of Two Oral Doses of Prurisol Administered Twice Daily for Twelve Weeks to Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 2/9/2018
Study Center
14
mi
from 91732
Los Angeles, CA
Click here to add this to my saved trials
Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis
A Randomized, Double Blind, Parallel Group, Placebo-controlled Trial to Study the Efficacy and Safety of Two Oral Doses of Prurisol Administered Twice Daily for Twelve Weeks to Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated:  2/9/2018
Clinical Study Site
1350
mi
from 91732
Rogers, AR
Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis
A Randomized, Double Blind, Parallel Group, Placebo-controlled Trial to Study the Efficacy and Safety of Two Oral Doses of Prurisol Administered Twice Daily for Twelve Weeks to Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 2/9/2018
Clinical Study Site
1350
mi
from 91732
Rogers, AR
Click here to add this to my saved trials
Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis
A Randomized, Double Blind, Parallel Group, Placebo-controlled Trial to Study the Efficacy and Safety of Two Oral Doses of Prurisol Administered Twice Daily for Twelve Weeks to Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated:  2/9/2018
Clinical Study Site
mi
from 91732
Clinton Township, MI
Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis
A Randomized, Double Blind, Parallel Group, Placebo-controlled Trial to Study the Efficacy and Safety of Two Oral Doses of Prurisol Administered Twice Daily for Twelve Weeks to Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 2/9/2018
Clinical Study Site
mi
from 91732
Clinton Township, MI
Click here to add this to my saved trials
Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Efficacy and Safety Study of Two Doses of Apremilast (CC-10004) in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated:  2/12/2018
Achieve Clinical Research
1787
mi
from 91732
Birmingham, AL
Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Efficacy and Safety Study of Two Doses of Apremilast (CC-10004) in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 2/12/2018
Achieve Clinical Research
1787
mi
from 91732
Birmingham, AL
Click here to add this to my saved trials
Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Efficacy and Safety Study of Two Doses of Apremilast (CC-10004) in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated:  2/12/2018
Arizona Research Center
340
mi
from 91732
Phoenix, AZ
Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Efficacy and Safety Study of Two Doses of Apremilast (CC-10004) in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 2/12/2018
Arizona Research Center
340
mi
from 91732
Phoenix, AZ
Click here to add this to my saved trials
Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Efficacy and Safety Study of Two Doses of Apremilast (CC-10004) in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated:  2/12/2018
North Florida Dermatology
2128
mi
from 91732
Jacksonville, FL
Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Efficacy and Safety Study of Two Doses of Apremilast (CC-10004) in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 2/12/2018
North Florida Dermatology
2128
mi
from 91732
Jacksonville, FL
Click here to add this to my saved trials
Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Efficacy and Safety Study of Two Doses of Apremilast (CC-10004) in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated:  2/12/2018
Tampa Medical Group, PA
2132
mi
from 91732
Tampa, FL
Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Efficacy and Safety Study of Two Doses of Apremilast (CC-10004) in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 2/12/2018
Tampa Medical Group, PA
2132
mi
from 91732
Tampa, FL
Click here to add this to my saved trials
Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Efficacy and Safety Study of Two Doses of Apremilast (CC-10004) in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated:  2/12/2018
Coeur D'Alene Arthritis Clinic
941
mi
from 91732
Coeur D'Alene, ID
Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Efficacy and Safety Study of Two Doses of Apremilast (CC-10004) in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 2/12/2018
Coeur D'Alene Arthritis Clinic
941
mi
from 91732
Coeur D'Alene, ID
Click here to add this to my saved trials
Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Efficacy and Safety Study of Two Doses of Apremilast (CC-10004) in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated:  2/12/2018
The Arthritis Center
1606
mi
from 91732
Springfield, IL
Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Efficacy and Safety Study of Two Doses of Apremilast (CC-10004) in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 2/12/2018
The Arthritis Center
1606
mi
from 91732
Springfield, IL
Click here to add this to my saved trials
Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Efficacy and Safety Study of Two Doses of Apremilast (CC-10004) in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated:  2/12/2018
St. Francis Hospital & Health Centers
1766
mi
from 91732
Michigan City, IN
Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Efficacy and Safety Study of Two Doses of Apremilast (CC-10004) in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 2/12/2018
St. Francis Hospital & Health Centers
1766
mi
from 91732
Michigan City, IN
Click here to add this to my saved trials
Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Efficacy and Safety Study of Two Doses of Apremilast (CC-10004) in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated:  2/12/2018
The Center for Rheumatology and Bone Research
2279
mi
from 91732
Wheaton, MD
Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Efficacy and Safety Study of Two Doses of Apremilast (CC-10004) in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 2/12/2018
The Center for Rheumatology and Bone Research
2279
mi
from 91732
Wheaton, MD
Click here to add this to my saved trials
Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Efficacy and Safety Study of Two Doses of Apremilast (CC-10004) in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated:  2/12/2018
Physician's East
2290
mi
from 91732
Greenville, NC
Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Efficacy and Safety Study of Two Doses of Apremilast (CC-10004) in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 2/12/2018
Physician's East
2290
mi
from 91732
Greenville, NC
Click here to add this to my saved trials
Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Efficacy and Safety Study of Two Doses of Apremilast (CC-10004) in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated:  2/12/2018
Piedmont Medical Research Associates
2123
mi
from 91732
Winston-Salem, NC
Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Efficacy and Safety Study of Two Doses of Apremilast (CC-10004) in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 2/12/2018
Piedmont Medical Research Associates
2123
mi
from 91732
Winston-Salem, NC
Click here to add this to my saved trials
Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Efficacy and Safety Study of Two Doses of Apremilast (CC-10004) in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated:  2/12/2018
Health Research of Oklahoma
1165
mi
from 91732
Oklahoma City, OK
Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Efficacy and Safety Study of Two Doses of Apremilast (CC-10004) in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 2/12/2018
Health Research of Oklahoma
1165
mi
from 91732
Oklahoma City, OK
Click here to add this to my saved trials
Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Efficacy and Safety Study of Two Doses of Apremilast (CC-10004) in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated:  2/12/2018
Dermatology Treatment & Research Center, PA
1223
mi
from 91732
Dallas, TX
Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Efficacy and Safety Study of Two Doses of Apremilast (CC-10004) in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 2/12/2018
Dermatology Treatment & Research Center, PA
1223
mi
from 91732
Dallas, TX
Click here to add this to my saved trials
Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Efficacy and Safety Study of Two Doses of Apremilast (CC-10004) in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated:  2/12/2018
Arthritis & Osteoporosis Associates, LLP
923
mi
from 91732
Lubbock, TX
Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Efficacy and Safety Study of Two Doses of Apremilast (CC-10004) in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 2/12/2018
Arthritis & Osteoporosis Associates, LLP
923
mi
from 91732
Lubbock, TX
Click here to add this to my saved trials
Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Efficacy and Safety Study of Two Doses of Apremilast (CC-10004) in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated:  2/12/2018
University of Utah
572
mi
from 91732
Salt Lake City, UT
Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Efficacy and Safety Study of Two Doses of Apremilast (CC-10004) in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 2/12/2018
University of Utah
572
mi
from 91732
Salt Lake City, UT
Click here to add this to my saved trials
Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Efficacy and Safety Study of Two Doses of Apremilast (CC-10004) in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated:  2/12/2018
Seattle Rheumatology Associates
961
mi
from 91732
Seattle, WA
Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Efficacy and Safety Study of Two Doses of Apremilast (CC-10004) in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 2/12/2018
Seattle Rheumatology Associates
961
mi
from 91732
Seattle, WA
Click here to add this to my saved trials